NeurAxis, Inc.
NRXS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.39 | 0.09 | -0.05 | 0.70 |
| FCF Yield | -4.69% | -7.15% | -10.11% | -10.81% |
| EV / EBITDA | -12.77 | -9.08 | -6.36 | -9.06 |
| Quality | ||||
| ROIC | -72.73% | -34.35% | -212.74% | -57.71% |
| Gross Margin | 83.30% | 83.60% | 84.43% | 86.20% |
| Cash Conversion Ratio | 0.67 | 0.87 | 0.70 | 1.21 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.78% | 6.24% | 2.57% | 0.01% |
| Free Cash Flow Growth | 3.20% | 9.06% | 7.76% | -25.84% |
| Safety | ||||
| Net Debt / EBITDA | 1.88 | 3.31 | 0.71 | 2.24 |
| Interest Coverage | -70.80 | -127.87 | -1,025.97 | -612.61 |
| Efficiency | ||||
| Inventory Turnover | 1.23 | 1.12 | 3.73 | 2.37 |
| Cash Conversion Cycle | -503.53 | -191.49 | -296.60 | -444.51 |